1 – 100 of 160
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Kataegis in clinical and molecular subgroups of primary breast cancer
(
- Contribution to journal › Article
-
Mark
Current and emerging sequencing-based tools for precision cancer medicine
(
- Contribution to journal › Scientific review
-
Mark
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC) : a pooled analysis of seven studies
(
- Contribution to journal › Article
-
Mark
Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway
(
- Contribution to journal › Article
-
Mark
Kataegis in clinical and molecular subgroups of primary breast cancer
2024) European Association for Cancer Research(
- Contribution to conference › Poster
-
Mark
Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases
(
- Contribution to journal › Article
- 2023
-
Mark
Improved detection of clinically relevant fusion transcripts in cancer by machine learning classification
(
- Contribution to journal › Article
-
Mark
Perturbation and stability of PAM50 subtyping in population-based primary invasive breast cancer
(
- Contribution to journal › Article
-
Mark
Perturbation and stability of PAM50 subtyping in population-based primary invasive breast cancer
2023) AACR Special Conference in Cancer Research: Advances in Breast Cancer Research(
- Contribution to conference › Poster
-
Mark
Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms
(
- Contribution to journal › Article
-
Mark
Molecular characteristics of lung adenocarcinoma with respect to patient age at diagnosis
(
- Contribution to journal › Article
-
Mark
A trans-omics assessment of gene–gene interaction in early-stage NSCLC
(
- Contribution to journal › Article
-
Mark
Molecular characteristics of breast tumors in patients screened for germline predisposition from a population-based observational study
(
- Contribution to journal › Article
- 2022
-
Mark
SRIQ clustering : A fusion of Random Forest, QT clustering, and KNN concepts
(
- Contribution to journal › Article
-
Mark
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
(
- Contribution to journal › Article
-
Mark
Feasibility of EBUS-TBNA for histopathological and molecular diagnostics of NSCLC-A retrospective single-center experience
(
- Contribution to journal › Article
-
Mark
Epigenome-wide three-way interaction study identifies a complex pattern between TRIM27, KIAA0226, and smoking associated with overall survival of early-stage NSCLC
(
- Contribution to journal › Article
-
Mark
Tumor purity adjusted beta values improve biological interpretability of high-dimensional DNA methylation data
(
- Contribution to journal › Article
-
Mark
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
(
- Contribution to journal › Published meeting abstract
- 2021
-
Mark
Pan-cancer application of a lung-adenocarcinoma-derived gene-expression-based prognostic predictor
(
- Contribution to journal › Article
-
Mark
Detection of Non-Small Lung Cell Carcinoma-Associated Genetic Alterations Using a NanoString Gene Expression Platform Approach
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy
(
- Contribution to journal › Article
-
Mark
Molecular analyses of triple-negative breast cancer in the young and elderly
(
- Contribution to journal › Article
-
Mark
Random forest modelling of high-dimensional mixed-type data for breast cancer classification
(
- Contribution to journal › Article
-
Mark
An Open Source, Automated Tumor Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer
(
- Contribution to journal › Article
-
Mark
A gene expression-based single sample predictor of lung adenocarcinoma molecular subtype and prognosis
(
- Contribution to journal › Article
-
Mark
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
(
- Contribution to journal › Article
-
Mark
Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer
(
- Contribution to journal › Article
-
Mark
Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms
(
- Contribution to journal › Article
- 2020
-
Mark
Analysis of human papillomaviruses and human polyomaviruses in lung cancer from Swedish never-smokers
(
- Contribution to journal › Letter
-
Mark
Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Sex differences in oncogenic mutational processes
(
- Contribution to journal › Article
-
Mark
Diagnostic value of insulinoma-associated protein 1 (INSM1) and comparison with established neuroendocrine markers in pulmonary cancers
(
- Contribution to journal › Article
-
Mark
Epigenetic–smoking interaction reveals histologically heterogeneous effects of TRIM27 DNA methylation on overall survival among early-stage NSCLC patients
(
- Contribution to journal › Article
-
Mark
Independent Validation of Early-Stage Non-Small Cell Lung Cancer Prognostic Scores Incorporating Epigenetic and Transcriptional Biomarkers With Gene-Gene Interactions and Main Effects
(
- Contribution to journal › Article
-
Mark
Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma
(
- Contribution to journal › Article
-
Mark
Epigenome-wide gene-age interaction analysis reveals reversed effects of PRODH DNA methylation on survival between young and elderly early-stage NSCLC patients
(
- Contribution to journal › Article
-
Mark
Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
(
- Contribution to journal › Article
-
Mark
Methylation patterns and chromatin accessibility in neuroendocrine lung cancer
(
- Contribution to journal › Article
-
Mark
Whole-genome sequencing of triple negative breast cancers in a standard population-based clinical setting
2020) UK Interdisciplinary Breast Cancer Symposium 2020 In Breast Cancer Research and Treatment 180. p.531-532(
- Contribution to journal › Published meeting abstract
-
Mark
Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma
(
- Contribution to journal › Article
- 2019
-
Mark
EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC
(
- Contribution to journal › Article
-
Mark
A combined gene expression tool for parallel histological prediction and gene fusion detection in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Clinical Application of Fusion Gene Detection Using Next-Generation Sequencing and the NanoString Technology
(
- Contribution to journal › Article
-
Mark
Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation
(
- Contribution to journal › Article
-
Mark
Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
(
- Contribution to journal › Article
-
Mark
Trans-omics biomarker model improves prognostic prediction accuracy for early-stage lung adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Prediction of lymph node metastasis in breast cancer by gene expression and clinicopathological models: Development and validation within a population based cohort.
(
- Contribution to journal › Article
-
Mark
Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
(
- Contribution to journal › Article
-
Mark
Pre-operative plasma cell-free circulating tumor DNA and serum protein tumor markers as predictors of lung adenocarcinoma recurrence
(
- Contribution to journal › Article
-
Mark
Performance of gene expression-based single sample predictors for assessment of clinicopathological subgroups and molecular subtypes in cancers : a case comparison study in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Mutational Landscape in Resected Periampullary Adenocarcinoma: Relationship With Morphology and Clinical Outcome
(
- Contribution to journal › Article
-
Mark
The circular RNome of primary breast cancer
(
- Contribution to journal › Article
-
Mark
SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival : an epigenomic–smoking interaction analysis
(
- Contribution to journal › Article
- 2018
-
Mark
Epigenetic modifications inlysine demethylases associate with survival of early-stage NSCLC
(
- Contribution to journal › Article
-
Mark
A multi-omic study reveals BTG2 as a reliable prognostic marker for early-stage non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer
(
- Contribution to journal › Article
-
Mark
DNA Methylation of LRRC3B : A Biomarker for Survival of Early-Stage Non-Small Cell Lung Cancer Patients
2018) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 27(12). p.1527-1535(
- Contribution to journal › Article
-
Mark
Mutational mechanisms of amplifications revealed by analysis of clustered rearrangements in breast cancers
2018) In Annals of Oncology(
- Contribution to journal › Article
-
Mark
Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors
(
- Contribution to journal › Article
-
Mark
Abstract P1-06-01: Putting multigene signatures to the test: Prognostic assessment in population-based contemporary clinical breast cancer
(
- Contribution to journal › Published meeting abstract
- 2017
-
Mark
A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers
(
- Contribution to journal › Article
-
Mark
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma
(
- Contribution to journal › Article
-
Mark
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries
(
- Contribution to journal › Article
-
Mark
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
(
- Contribution to journal › Article
-
Mark
NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics
(
- Contribution to journal › Article
-
Mark
Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Myc-induced glutaminolysis bypasses HIF-driven glycolysis in hypoxic small cell lung carcinoma cells
(
- Contribution to journal › Article
-
Mark
Gene expression profiling of large cell lung cancer links transcriptional phenotypes to the new histological WHO2015 classification
(
- Contribution to journal › Article
-
Mark
Targeted sequencing may facilitate differential diagnostics of pulmonary tumours: a case series
(
- Contribution to journal › Article
- 2016
-
Mark
Prognostic and chemotherapy predictive value of gene-expression phenotypes in primary lung adenocarcinoma.
(
- Contribution to journal › Article
-
Mark
An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
(
- Contribution to journal › Article
-
Mark
The topography of mutational processes in breast cancer genomes
(
- Contribution to journal › Article
-
Mark
Consensus of Melanoma Gene Expression Subtypes Converges on Biological Entities
(
- Contribution to journal › Letter
-
Mark
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
(
- Contribution to journal › Article
-
Mark
Consensus of gene expression phenotypes and prognostic risk predictors in primary lung adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration
(
- Contribution to journal › Article
-
Mark
Spatial Transcriptomics. Digital Pathology to Investigate Intratumor Heterogeneity in Breast Cancer.
2016) AGBT Advances in Genome Biology and Technology meeting.(
- Contribution to conference › Poster
- 2015
-
Mark
Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer.
(
- Contribution to journal › Article
-
Mark
DNA methylation subgroups in melanoma are associated with proliferative and immunological processes.
(
- Contribution to journal › Article
-
Mark
Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation.
(
- Contribution to journal › Article
-
Mark
Molecular stratification of metastatic melanoma using gene expression profiling: prediction of survival outcome and benefit from molecular targeted therapy.
(
- Contribution to journal › Article
-
Mark
Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours.
(
- Contribution to journal › Article
-
Mark
Making breast cancer molecular subtypes robust?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Genome methylation patterns in male breast cancer - Identification of an epitype with hypermethylation of polycomb target genes.
(
- Contribution to journal › Article
- 2014
-
Mark
Primary Melanoma Tumors from CDKN2A Mutation Carriers do not Belong to a Distinct Molecular Subclass.
(
- Contribution to journal › Article
-
Mark
Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome.
(
- Contribution to journal › Article
-
Mark
Genomic and transcriptional alterations in lung adenocarcinoma in relation to smoking history.
(
- Contribution to journal › Article
-
Mark
Molecular and genetic diversity in the metastatic process of melanoma.
(
- Contribution to journal › Article
- 2013
-
Mark
Detailed Analysis of Focal Chromosome Arm 1q and 6p Amplifications in Urothelial Carcinoma Reveals Complex Genomic Events on 1q, and SOX4 as a Possible Auxiliary Target on 6p.
(
- Contribution to journal › Article
-
Mark
High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancer
(
- Contribution to journal › Article
-
Mark
Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to EGFR and KRAS Mutation Status.
(
- Contribution to journal › Article
-
Mark
Histological specificity of alterations and expression of KIT and KITLG in non-small cell lung carcinoma.
(
- Contribution to journal › Article
-
Mark
Detecting EGFR alterations in clinical specimens-pitfalls and necessities.
(
- Contribution to journal › Article
-
Mark
Identification of transcriptional subgroups in EGFR-mutated and EGFR/KRAS-wild type lung adenocarcinoma reveals gene signatures associated with patient outcome.
(
- Contribution to journal › Article
-
Mark
Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
(
- Contribution to journal › Article
-
Mark
Nonfamilial breast cancer subtypes.
(
- Contribution to journal › Scientific review
- 2012
-
Mark
Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma.
(
- Contribution to journal › Article
-
Mark
Relation between smoking history and gene expression profiles in lung adenocarcinomas
(
- Contribution to journal › Article
-
Mark
The gene expression landscape of breast cancer is shaped by tumor protein p53 status and epithelial-mesenchymal transition
(
- Contribution to journal › Article